Earlier studies of our own found that TNKS1 and β-catenin were dramatically upregulated in glioma tissues when matched against normal brain tissue, implying that Wnt/β-catenin pathway may be a vital part of glioma as a classical signaling pathway positive regulator [24]. The gene discussed is TNKS; the disease is central nervous system cancer.